Restricted Cash

3 Months Ended

Mar. 31, 2021

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]

Cash And Cash Equivalents Disclosure [Text Block]

Note 13 – Restricted Cash

Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary

of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an

original total value of $35.0 million. The proceeds of both settlements were restricted and could only be used to pay claims and costs

of defense associated with the subsidiary’s asbestos litigation. The proceeds of the settlement and release agreements were deposited

into interest bearing accounts that earned less than $0.1 million offset by $0.2 million of net payments during the three months ended

March 31, 2020.

 Due to the restricted nature of the proceeds, a corresponding deferred credit was established in other non-current

liabilities for an equal and offsetting amount that continued until the restrictions lapsed. As disclosed in the Company’s 2020 Form

10-K, during December 2020, the restrictions ended on these previously received insurance settlements and the Company transferred

the cash into an operating account. 

The following table provides a reconciliation of cash, cash equivalents and restricted cash as of March 31, 2021 and 2020, as well

as December 31, 2020 and 2019:

March 31, 

December 31,

2021

2020

2020

2019

Cash and cash equivalents

$

163,455

$

316,437

$

181,833

$

123,524

Restricted cash included in other current assets

—

34

62

353

Restricted cash included in other assets

—

19,480

—

19,678

Cash, cash equivalents and restricted cash

$

163,455

$

335,951

$

181,895

$

143,555